Evidence map›Paper›PMID 36124059›Full record

ArticleCommunications medicine2022

Germany's fourth COVID-19 wave was mainly driven by the unvaccinated.

Benjamin F Maier, Marc Wiedermann, Angelique Burdinski, Pascal P Klamser, Mirjam A Jenny, Cornelia Betsch, Dirk Brockmann

Open access · goldAbstract read
In one paragraph

Article in Communications medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Nationwide population-based infection- and vaccine-induced SARS-CoV-2 antibody seroprevalence in Germany in autumn/winter 2021/2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Study of the Deep Processes of COVID-19 in Russia: Finding Ways to Identify Preventive Measures.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Benjamin F MaierInstitute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt-University of Berlin, Philippstr. 13, 10115 Berlin, Germany.ORCID 0000-0001-7414-8823
Marc WiedermannInstitute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt-University of Berlin, Philippstr. 13, 10115 Berlin, Germany.ORCID 0000-0001-9869-3789
Angelique BurdinskiInstitute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt-University of Berlin, Philippstr. 13, 10115 Berlin, Germany.ORCID 0000-0002-9305-1493
Pascal P KlamserInstitute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt-University of Berlin, Philippstr. 13, 10115 Berlin, Germany.ORCID 0000-0003-2208-4391
Mirjam A JennyUniversity of Erfurt, Nordhäuserstr. 63, 99089 Erfurt, Germany.ORCID 0000-0002-5045-5105
Cornelia BetschUniversity of Erfurt, Nordhäuserstr. 63, 99089 Erfurt, Germany.ORCID 0000-0002-2856-7303
Dirk BrockmannInstitute for Theoretical Biology and Integrated Research Institute for the Life-Sciences, Humboldt-University of Berlin, Philippstr. 13, 10115 Berlin, Germany.ORCID 0000-0001-5708-2922
Robert Koch Institute · DEHumboldt-Universität zu Berlin · DEUniversity of Erfurt · DEUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While the majority of the German population was fully vaccinated at the time (about 65%), COVID-19 incidence started growing exponentially in October 2021 with about 41% of recorded new cases aged twelve or above being symptomatic breakthrough infections, presumably also contributing to the dynamics. So far, it remained elusive how significant this contribution was and whether targeted non-pharmaceutical interventions (NPIs) may have stopped the amplification of the crisis. Methods: We develop and introduce a contribution matrix approach based on the next-generation matrix of a population-structured compartmental infectious disease model to derive contributions of respective inter- and intragroup infection pathways of unvaccinated and vaccinated subpopulations to the effective reproduction number and new infections, considering empirical data of vaccine efficacies against infection and transmission. Results: Here we show that about 61%-76% of all new infections were caused by unvaccinated individuals and only 24%-39% were caused by the vaccinated. Furthermore, 32%-51% of new infections were likely caused by unvaccinated infecting other unvaccinated. Decreasing the transmissibility of the unvaccinated by, e. g. targeted NPIs, causes a steeper decrease in the effective reproduction number Conclusions: A minority of the German population-the unvaccinated-is assumed to have caused the majority of new infections in the fall of 2021 in Germany. Our results highlight the importance of combined measures, such as vaccination campaigns and targeted contact reductions to achieve temporary epidemic control.

Indexed as

Computational biology and bioinformaticsViral infection

Identifiers

PMID36124059
PMCPMC9481603
OpenAlexW4296205343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.